The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Frontiers in Oncology
(May 2022)
Commentary: Treatment Outcome of Different Chemotherapy in Patients With Relapsed or Metastatic Malignant Urachal Tumor
Tibor Szarvas,
Tibor Szarvas,
Henning Reis
Affiliations
Tibor Szarvas
Department of Urology, University Medicine Essen, University of Duisburg-Essen, Essen, Germany
Tibor Szarvas
Department of Urology, Semmelweis University, Budapest, Hungary
Henning Reis
Dr. Senckenberg Institute of Pathology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany
DOI
https://doi.org/10.3389/fonc.2022.864708
Journal volume & issue
Vol. 12
Abstract
Read online
No abstracts available.
Keywords
urachal cancer
chemotherapy
cisplatin
outcome
survival
molecular pathology
WeChat QR code
Close